Medroxyprogesterone Compared With Venlafaxine in Treating Hot Flashes in Women - Related Studies

Medroxyprogesterone Compared With Venlafaxine in Treating Hot Flashes in Women

This study has been completed.

Study NCT00030914. Last updated on October 18, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Cancer-Related Problem/Condition

2	Additional conditions recognized in this trial
		Hot Flashes

3	More general conditions related to this trial
		Signs and Symptoms

4	Interventions listed in this trial
		medroxyprogesterone
		venlafaxine

5	Additional drug interventions recognized in this trial
		Medroxyprogesterone 17-Acetate

6	More general drug interventions related to this trial
		Antidepressive Agents
		Antidepressive Agents, Second-Generation
		Antineoplastic Agents
		Antineoplastic Agents, Hormonal
		Central Nervous System Agents
		Contraceptive Agents
		Contraceptive Agents, Female
		Contraceptive Agents, Male
		Contraceptives, Oral
		Contraceptives, Oral, Synthetic
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Neurotransmitter Uptake Inhibitors
		Pharmacologic Actions
		Physiological Effects of Drugs
		Psychotropic Drugs
		Reproductive Control Agents
		Serotonin Agents
		Serotonin Uptake Inhibitors
		Therapeutic Uses

7	Sponsors listed in this trial
		North Central Cancer Treatment Group
		National Cancer Institute (NCI)